- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Isatuximab Carfilzomib Lenalidomide Dexamethasone
Total 487 results
-
Bristol-Myers SquibbCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Michaela LiedtkeCelgene CorporationCompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthAmgenRecruitingMultiple MyelomaUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); City of Hope Medical Center and other collaboratorsCompletedRecurrent Plasma Cell MyelomaUnited States
-
Washington University School of MedicineCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of Heidelberg Medical CenterJanssen Research & Development, LLC; Deutsche Studiengruppe Multiples Myelom...Recruiting
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaBelgium, Korea, Republic of, Australia, United Kingdom, France, Sweden, Spain, Turkey, Italy, Czechia, Netherlands, Poland, Switzerland, Germany
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Japan, Netherlands, France, Brazil, Poland, Spain
-
TakedaActive, not recruiting
-
University of ArkansasWithdrawn
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
-
Massachusetts General HospitalMultiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
MorphoSys AGCompletedMultiple MyelomaAustria, Germany
-
Bristol-Myers SquibbCompleted
-
University of ArkansasWithdrawn
-
Elvira UmyarovaSanofiRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknown
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited Kingdom, United States, France, Netherlands, Denmark
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaHong Kong, Korea, Republic of, Singapore
-
Gruppo Italiano Studio LinfomiUnknown
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico, Germany
-
National University Hospital, SingaporeNational University of SingaporeRecruiting
-
Vanderbilt-Ingram Cancer CenterCompleted
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Ajai ChariNovartis PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Leap Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnMultiple Myeloma | Plasma Cell MyelomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Millennium Pharmaceuticals, Inc.Completed
-
Cantonal Hospital of St. GallenCelgene Corporation; Amgen; Mundipharma Medical Company; Mundipharma Research GmbH...Completed
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada